Medical Advisory Board

The mission of Living Beyond Breast Cancer’s Medical Advisory Board is to serve as an expert resource on issues of concern to people affected by breast cancer and their families and to assist with outreach to other health professionals and consumers about the breadth of LBBC programs for people affected by breast cancer.

Many Medical Advisory Board members help with reviewing content for our website and publications, serve as speakers at our events and help answer your questions about breast cancer during our ask-the-expert series.

 

  • Dr. Cheville is associate professor of physical medicine and rehabilitation at the Mayo Clinic in Rochester, Minn., where she researches lymphedema and serves as chair and division chair for cancer rehabilitation and lymphedema services. Her research focuses on protecting the lymphatic system during primary breast cancer treatment and enhancing its innate capacity to heal, novel care delivery models for long-term lymphedema management, as well as strategies to reduce cancer-related lymphedema risk.

  • Dr. Conant is professor of radiology and chief of breast imaging at University of Pennsylvania.

  • Helen L. Coons, Ph.D., ABPP is a board certified clinical health psychologist who has worked with women with cancer, oncology health care teams and the cancer advocacy community for over 25 years. She routinely provides care to women across the life span with early and advanced breast, gynecologic and other cancer diagnoses as well as women at “high risk” for cancer and their caregivers.

  • Dr. Copit is assistant clinical professor in the division of plastic surgery at Thomas Jefferson University.

  • Wendy Demark-Wahnefried, PhD, RD is associate director for cancer prevention and control with the UAB Comprehensive Cancer Center, as well as a professor of nutrition sciences.

  • Dr. DeMichele is a professor of medicine and epidemiology at the University of Pennsylvania focusing on breast cancer oncology and molecular epidemiology. Through her research, she seeks to identify markers of outcome and response to therapy, as well as develop targeted therapeutics.